BridgeBio Pharma
Price & Volume
Stats
See moreOpen | $79.32 |
Previous Close | $78.68 |
Day Range | $76.83-$79.32 |
52W Range | $48.78-$93.41 |
Market Cap | $15.5B |
Shares Short | 23M |
Financials
See moreRevenue (12 Mos) | $713M |
Revenue Growth (YoY) | 120.4% |
Gross Profit (12 Mos) | $673.4M |
Diluted EPS | -$3.52 |
News
See moreYahoo Finance • 6 hours ago
Alnylam drops as AstraZeneca posts full trial results for failed heart drug
Yahoo Finance • 3 days ago
BridgeBio Q2 Sales Jump 120% as Attruby Drives Commercial Momentum
Yahoo Finance • 3 days ago
Is BBIO a Buy as Fast Sales Growth Meets a Steep Valuation Premium?
Yahoo Finance • 3 days ago
Why BBIO Rose 24% in Three Months and Whether the Rally Can Continue
About
CEO | Dr. Neil Kumar Ph.D. |
CFO | Dr. Thomas Trimarchi Ph.D. |
Address | 3160 Porter Drive, Palo Alto, CA, United States, 94304 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 999 |